In conclusion, we have evaluated the multiplex capabilities of a novel flow analyzer by reconfiguring a previous FMIA for SARS-CoV-2, and have simultaneously described the IgM and IgG antibody response in our COVID-19 case population. The gene discussed is CD40LG; the disease is COVID-19.